Page last updated: 2024-10-30

metformin and Glenoid Labral Tears

metformin has been researched along with Glenoid Labral Tears in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin 50 mg/kg was intraperitoneally injected for 5 days."1.91Metformin increases the expression of proinflammatory cytokines and inhibits supraspinatus fatty infiltration. ( Chung, SW; Kim, DH; Park, SJ; Yoon, JP, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Yoon, JP1
Park, SJ1
Kim, DH1
Chung, SW1
Aung, TKK1
Chuah, TY1
Chua, MWJ1

Other Studies

2 other studies available for metformin and Glenoid Labral Tears

ArticleYear
Metformin increases the expression of proinflammatory cytokines and inhibits supraspinatus fatty infiltration.
    Journal of orthopaedic surgery and research, 2023, Sep-12, Volume: 18, Issue:1

    Topics: Animals; Cytokines; Male; Metformin; Rats; Rats, Sprague-Dawley; Rotator Cuff; Rotator Cuff Injuries

2023
More Than Meets the Eye: A Patient with Hand Swelling and Newly Diagnosed Diabetes Mellitus.
    The American journal of medicine, 2021, Volume: 134, Issue:11

    Topics: Aged; Amlodipine; Anemia; Antihypertensive Agents; Blood Sedimentation; C-Reactive Protein; Diabetes

2021